Common Contracts
3 similar Securities Purchase Agreement contracts by Onconova Therapeutics, Inc.
SECURITIES PURCHASE AGREEMENT By and Between ONCONOVA THERAPEUTICS, INC. and HANX BIOPHARMACEUTICALS, INC. Dated as of May 10, 2019Securities Purchase Agreement • August 14th, 2019 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 10, 2019 (the “Signing Date”), by and between Onconova Therapeutics, Inc., a Delaware corporation (the “Company”), and HanX Biopharmaceuticals, Inc., a limited liability company established under the laws of the People’s Republic of China (the “Purchaser”).
SECURITIES PURCHASE AGREEMENT By and Between ONCONOVA THERAPEUTICS, INC. and ABUNDANT NEW INVESTMENTS LTD. Dated as of May 10, 2019Securities Purchase Agreement • August 14th, 2019 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 10, 2019 (the “Signing Date”), by and between Onconova Therapeutics, Inc., a Delaware corporation (the “Company”), and Abundant New Investments Ltd., a company established under the laws of the British Virgin Islands (the “Purchaser”).
SECURITIES PURCHASE AGREEMENT By and Between ONCONOVA THERAPEUTICS, INC. and PINT PHARMA GMBH Dated as of March 2, 2018Securities Purchase Agreement • May 15th, 2018 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of March 2, 2018 (the “Signing Date”), by and between Onconova Therapeutics, Inc., a Delaware corporation (the “Company”), and Pint Pharma GmbH, with its registered office located at Wipplingerstrasse 34, Top 112 - 119, AT-1010 Vienna (the “Purchaser”).
